Tuberculosis treatment success rate in Mauritania
Mauritania: Tuberculosis treatment success rate was 84.0% in 2022. ▲ Rising
Tuberculosis treatment success rate in Mauritania, 2003–2022
Source: WHO (2025) – with minor processing by Our World in Data. Measured in %.
Analysis
The most recent figure for tuberculosis treatment success rate in Mauritania is 84.0%, measured in 2022. That is the highest value across all 20 years on record.
Compared with earlier readings it is up 1.2% on the previous year and up 23.5% over ten years.
Over the whole period, tuberculosis treatment success rate in Mauritania peaked at 84.0% in 2022 and was at its lowest, 22.0%, in 2004.
Mauritania ranks 98th of 206 countries on this measure, in the middle of the range.
The long-run direction has been consistently rising across the 20 years of available data.
Tuberculosis treatment success rate in Mauritania, year by year
| Year | % | Change |
|---|---|---|
| 2003 | 58.0% | — |
| 2004 | 22.0% | -62.1% |
| 2005 | 55.0% | +150.0% |
| 2006 | 41.0% | -25.5% |
| 2007 | 66.0% | +61.0% |
| 2008 | 68.0% | +3.0% |
| 2009 | 60.0% | -11.8% |
| 2010 | 70.0% | +16.7% |
| 2011 | 70.0% | +0.0% |
| 2012 | 68.0% | -2.9% |
| 2013 | 71.0% | +4.4% |
| 2014 | 70.0% | -1.4% |
| 2015 | 71.0% | +1.4% |
| 2016 | 70.0% | -1.4% |
| 2017 | 77.0% | +10.0% |
| 2018 | 81.0% | +5.2% |
| 2019 | 81.0% | +0.0% |
| 2020 | 75.0% | -7.4% |
| 2021 | 83.0% | +10.7% |
| 2022 | 84.0% | +1.2% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 52.9% | 22.0% | 68.0% | 7 |
| 2010s | 72.9% | 68.0% | 81.0% | 10 |
| 2020s | 80.7% | 75.0% | 84.0% | 3 |
Countries ranked near Mauritania
- 98 Azerbaijan 84.0% compare
- 98 Bhutan 84.0% compare
- 98 Botswana 84.0% compare
- 98 Chad 84.0% compare
- 98 Djibouti 84.0% compare
- 98 Honduras 84.0% compare
- 98 Jordan 84.0% compare
- 98 Mali 84.0% compare
- 98 Myanmar 84.0% compare
- 98 Philippines 84.0% compare
- 98 Romania 84.0% compare
- 98 Turkmenistan 84.0% compare
- 98 Venezuela, Bolivarian Republic of 84.0% compare
More health data for Mauritania
- Un projection of annual infant deaths, annual growth rate -0.8878 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.19 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 653 deaths per 1,000 people (2090)
- Number of infants who die before age 1 1,563 deaths (2100)
- Population ages 65-69, male, annual growth rate 3.37 % change on previous year (2025)
- Population ages 65-69, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 65-69, male, per capita 0.0063 units per person (2025)
- Population ages 70-74, female, annual growth rate 4.49 % change on previous year (2025)
- Population ages 70-74, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 70-74, female, per capita 0.0049 units per person (2025)
Frequently asked questions
- What is tuberculosis treatment success rate in Mauritania?
- Tuberculosis treatment success rate in Mauritania was 84.0% in 2022, according to WHO (2025) – with minor processing by Our World in Data.
- What is the highest tuberculosis treatment success rate recorded in Mauritania?
- The highest recorded value was 84.0% in 2022.
- What is the lowest tuberculosis treatment success rate recorded in Mauritania?
- The lowest recorded value was 22.0% in 2004.
- How does Mauritania rank for tuberculosis treatment success rate?
- Mauritania ranks 98th out of 206 countries with data for 2022.
- Is tuberculosis treatment success rate rising or falling in Mauritania?
- Over the last ten years it is up 23.5%. The long-run trend across the full record is rising.
- Where does this Mauritania data come from?
- The figures come from WHO (2025) – with minor processing by Our World in Data, published as part of Tuberculosis treatment success rate. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 20 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Treatment success rate among new and relapse cases.